top of page
Ropinirole

Mechanism of action:
Ropinirole is a dopamine receptor agonist. Ropinirole has relatively high affinity for D2 and D3 receptors. After receptor activation, it inhibits adenylyl cyclase through Gi/o protein coupling, lowers cAMP levels, and reduces excessive activation of inhibitory output nuclei such as the globus pallidus internus.
Reference(s):
1. Matheson AJ et al. (2000). Ropinirole: a review of its use in the management of Parkinson's disease. Drugs.
2. Nashatizadeh MM et al. (2009). A review of ropinirole prolonged release in Parkinson's disease. Clin Interv Aging.
3. Kushida CA et al. (2006). Ropinirole for the treatment of restless legs syndrome. Neuropsychiatr Dis Treat.
bottom of page
